Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised …
…, SA Lazarev, LW Lee, ID Lifirenko, D Martincic… - The Lancet, 2019 - thelancet.com
Background There are few effective treatment options for patients with recurrent or metastatic
head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and …
head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and …
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
…, R Rifkin, H Yimer, R McCroskey, D Martincic… - The Lancet …, 2019 - thelancet.com
Background Lenalidomide and dexamethasone has been a standard of care in transplant-ineligible
patients with newly diagnosed multiple myeloma. The addition of a third drug to the …
patients with newly diagnosed multiple myeloma. The addition of a third drug to the …
Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients
H Kaya, B Peressini, I Jawed, D Martincic… - International journal of …, 2012 - Springer
With the availability of novel agents, the overall survival (OS) in patients diagnosed with
multiple myeloma (MM) has improved over the last decade. Data on 40,294 MM patients in the …
multiple myeloma (MM) has improved over the last decade. Data on 40,294 MM patients in the …
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic …
Purpose Cetuximab (C), a chimeric monoclonal antibody that binds epidermal growth factor
receptor (EGFR), is active against androgen-independent prostate cancer cell lines and …
receptor (EGFR), is active against androgen-independent prostate cancer cell lines and …
Factor XI messenger RNA in human platelets
D Martincic, V Kravtsov, D Gailani - Blood, The Journal of the …, 1999 - ashpublications.org
The bleeding diathesis associated with congenital deficiency of factor XI (FXI) is variable
and correlates poorly with standard coagulation assays. Platelets are reported to contain FXI …
and correlates poorly with standard coagulation assays. Platelets are reported to contain FXI …
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
…, F Lim, A Madroszyk-Flandin, O Marathe, D Martincic… - Annals of …, 2024 - Elsevier
Background Checkpoint inhibitor (CPI) therapy revolutionized treatment for advanced non-small-cell
lung cancer (NSCLC); however, most patients progress due to primary or acquired …
lung cancer (NSCLC); however, most patients progress due to primary or acquired …
Familial thrombophilia associated with fibrinogen Paris V: Dusart syndrome
T Tarumi, D Martincic, A Thomas… - Blood, The Journal …, 2000 - ashpublications.org
We report on a family with a history of venous thromboembolism associated with fibrinogen
Paris V (fibrinogen A-Arg554→Cys). Ten members experienced thrombotic events, …
Paris V (fibrinogen A-Arg554→Cys). Ten members experienced thrombotic events, …
Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting
D Martincic, SA Zimmerman, RE Ware… - Blood, The Journal …, 1998 - ashpublications.org
Congenital deficiency of factor XI is a rare condition associated with a mild to moderate
bleeding diathesis that is most commonly found in persons of Jewish ancestry. The disorder has …
bleeding diathesis that is most commonly found in persons of Jewish ancestry. The disorder has …
Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis
Objective: The standard adjuvant treatment for men with stage I testicular seminoma remains
controversial within the literature. We analyzed survival rates in men with stage I seminoma …
controversial within the literature. We analyzed survival rates in men with stage I seminoma …
Transforming growth factor b as a potential tumor progression factor among hyperdiploid glioblastoma cultures: Evidence for the role of platelet-derived growth factor
…, CE Hart, PA Commers, JA Whitlock, D Martincic… - Journal of neuro …, 1997 - Springer
Among early-passage, near-diploid gliomas in vitro, transforming growth factor type β (TGFβ)
has been previously shown to be an autocrine growth inhibitor. In contrast, hyperdiploid (≥ …
has been previously shown to be an autocrine growth inhibitor. In contrast, hyperdiploid (≥ …
